PMHNP Practice Authority in Wisconsin: Independence, Physician Agreements and Schedule II

AANP's May 2026 map puts Wisconsin in its reduced tier, and the label is AANP's advocacy classification, not a legal category.

It also predates the current statute: 2025 Wisconsin Act 17 took effect September 1, 2026.

The legal default is § 441.09(3m)(a) 1. — an APRN licensed under the section practices only in collaboration with a physician or dentist, with an exception for APRNs holding a certified nurse-midwife specialty designation and for the board-verified route in par. (b).

For a new graduate the practical starting point is collaborative practice; independence is applied for and verified by the board, not carried by the license from day one.

Board-verified independence under § 441.09(3m)(b) requires four conditions together.

Subdivision 1: 3,840 hours of professional nursing in a clinical setting — clinical hours completed as a requirement of a nursing program at a qualifying school count, but hours completed to satisfy an APRN education program do not.

Subdivision 2: at least 24 months must have elapsed since the APRN first began completing those nursing-program clinical hours, so the first clock starts with nursing school.

Subdivision 3: 3,840 clinical hours of APRN practice in the recognized role with a physician or dentist who was immediately available for consultation and accepted responsibility; additional APRN hours substitute hour-for-hour toward subdivision 1.

Subdivision 4: at least 24 months since the APRN first began practicing in that role.

Out-of-state APRN hours and in-state APRN practice before September 1, 2026 both count (3m)(bd).

The statute defines the collaboration it requires and puts the documentation duty on the APRN.

It names no form to file, no meeting frequency, no chart-review percentage and no cap on how many APRNs one physician or dentist may work with.

The collaborator must be a physician or a dentist; for the qualifying 3,840 APRN hours under (3m)(b) 3., that physician or dentist must have been immediately available for consultation and must have accepted responsibility for the APRN's actions, so a supervisor's availability is part of what an associate is choosing.

An employer may still impose additional requirements as a condition of employment or relationship (3m)(c), and beyond-expertise situations trigger a professional-standards duty to consult, collaborate or refer (3m)(d).

Section 441.09(2)(a) lets an APRN issue prescription orders, subject to board rules on prescribing scope and barred drug classes.

Under the existing rule, Schedule I is barred outright (N 8.06(2)), and Schedule II amphetamines and sympathomimetic amines are restricted by indication, not by setting or supervision.

Because treatment of hyperkinesis, including attention deficit hyperactivity disorder, is listed, an outpatient Wisconsin PMHNP can prescribe Schedule II ADHD stimulants for it under the rule as printed; orders must stay within the prescriber's own areas of competence (N 8.06(1)), and each order carries the board-issued license number (§ 961.395(2)).

The caveat is statutory: N 8 was promulgated under the old § 441.16(3), and § 961.395(1), as amended by Act 17 § 171, now provides that an APRN who may issue prescription orders under § 441.09(2) may prescribe controlled substances only as permitted by the rules promulgated under § 441.09(6)(a) 4.

Whether the N 8.06(3) indications carry over under that cross-reference is not stated in the sources read — confirm with the Board of Nursing before relying on it.

The license carries the titles: A.P.R.N. (§ 441.09(3)(a) 1.), N.P. with the nurse practitioner specialty designation (§ 441.09(3)(b) 2.d.).

A no-prescribing notation appears only where the APRN qualified under the January 1, 2026 practising-RN route — satisfying par. (a) 2. b. but not the graduate-program route with national certification in par. (a) 2. a. — or was grandfathered as a § 441.15 nurse-midwife (subd.

1. c.), and held no § 441.16(2) certificate on January 1, 2026; such an APRN may not issue prescription orders (§ 441.09(1)(b) 5., (2)(b)).

Practice requires malpractice liability insurance at all times (§ 441.09(5)), and each biennium at least 16 contact hours of continuing education in clinical pharmacology or therapeutics relevant to the area of practice (§ 441.09(4)).

Independence does not lift everything: invasive pain-management techniques require collaboration with a physician who specializes in pain management regardless of independence (§ 441.09(3m)(bg) 1.), except for an independent APRN treating in a hospital or hospital-associated clinic (3m)(bg) 2., or holding hospital privileges to provide that treatment without a collaborative relationship with a physician (3m)(bg) 3., subject to (3m)(c).

Wisconsin has not enacted the APRN Compact; it was not among the enacting states found (Delaware, North Dakota, South Dakota, Utah and Wyoming).

The compact takes effect only once seven states enact it, and as of September 2026 five had, so no APRN holds a multistate APRN license today.

The Nurse Licensure Compact is an RN compact and gives no nurse practitioner authority in another state.

A PMHNP moving to Wisconsin needs a Wisconsin APRN license, and any collaborative-practice period starts under § 441.09(3m)(a) 1. unless the board has already verified the APRN for independent practice.

Act 17 was enacted August 8, 2025 and published August 9, 2025; under § 173 it takes effect on the first day of the 13th month beginning after publication — September 1, 2026.

Section 116 created the § 441.09 APRN license, and §§ 119, 120, 122, 123 and 124 repealed the § 441.16 advanced practice nurse prescriber certificate, the § 441.15 nurse-midwife license and § 441.11 (title, (1) and (3)) — except § 441.11(2), which § 121 renumbered to § 441.09(5m), the licensure exemption for CRNA-designated APRNs.

Holders of a § 441.16 prescriber certificate on August 31, 2026 are granted the APRN license.

The continue-practising clause, § 172(2)(b), let an RN who was licensed and practicing in a recognized role on January 1, 2026 keep practicing while the board took final action on their application — but the paragraph 'does not apply after the first day of the 13th month beginning after the effective date of this paragraph,' so it is time-limited, not open-ended.

Because AANP's map is dated 05/2026, its reduced label describes the pre-Act-17 system.

A Wisconsin PMHNP registers with the DEA as a mid-level practitioner, and that registration covers only what state law lets the APRN prescribe — the DEA form never widens the state limits.

The DEA and HHS telemedicine flexibilities, extended by the Fourth Temporary Rule effective January 1, 2026 through December 31, 2026, let DEA-registered practitioners prescribe Schedules II–V remotely without an in-person medical evaluation, but they lift no Wisconsin condition: the collaborative-practice default and the controlled-substance limits still govern, and the flexibilities end December 31, 2026 unless extended again.

Wisconsin's own controlled-substance limit on APRN prescribing is § 961.395(1) — controlled substances only as permitted by the rules under § 441.09(6)(a) 4.

Whether a separate state controlled-substance registration is also required was not stated in the sources read.